Sun, Aug 31, 2014, 3:35 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Sony Corporation Message Board

repo_man_one 54 posts  |  Last Activity: Aug 27, 2014 7:56 PM Member since: Sep 6, 2012
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • repo_man_one repo_man_one Jun 2, 2014 1:21 PM Flag

    So this must mean your work here is complete, right?
    No more need for your gibberish.

  • repo_man_one by repo_man_one Jun 2, 2014 1:28 PM Flag

    Interesting ne Featured Video clip on the Roskamp site.

    Google Dr Mullan CEO Roskamp to watch

  • “The National Institutes of Health is announcing the launch of a new longitudinal research effort to detect, characterize, and measure the chronic effects of repetitive concussions to inform clinical trials aimed at preventing or slowing disease progression in the future. NIH is being supported by the Foundation for the National Institutes of Health, starting with an initial investment of $16 million from its first Sports Health Program partner, the National Football League. This funding, together with grants announced at the end of last year, fulfill the $30 million commitment the NFL made to the NIH in 2012. This fall, the NIH will convene public and private funders of concussion and TBI research, including NIH, the NFL, DoD, and NCAA, with the goal of supporting enhanced coordination among research efforts and better leveraging of public and private investments to accelerate research outcomes.”

    Google – President Applauds Commitments to Address Sports-Related Concussions
    To read the full White House press release.

    Note the part “to inform the clinical trials..”

    WHooo - What clinical trails?

    And then we also know this from RCPI’s 3Q 10Q:

    “The study, which was funded by the Department of Defense and the Roskamp Foundation, used a published preclinical laboratory model of mild repetitive TBI, developed by the Roskamp team, which demonstrates cognitive impairment and neuropathological changes consistent with human TBI patients. Dr. Ferguson showed that chronic treatment with anatabine significantly improved cognitive performance in the TBI group, and significantly reduced TBI-induced inflammatory responses in the brain. The significance of repetitive mild brain injury, and its negative long term consequences on health, has become increasingly evident over the past few years both from military statistics on TBI in troops, and the data from athletes such as NFL players who have suffered multiple concussions...."

  • repo_man_one repo_man_one Jun 5, 2014 9:15 AM Flag

    Isn't it interesting how the shorts want to shout Anatabloc doesn't work, or is a scam but they avoid this TBI topic by trying to change the subject?

  • “The National Institutes of Health is announcing the launch of a new longitudinal research effort to detect, characterize, and measure the chronic effects of repetitive concussions to inform clinical trials aimed at preventing or slowing disease progression in the future. NIH is being supported by the Foundation for the National Institutes of Health, starting with an initial investment of $16 million from its first Sports Health Program partner, the National Football League. This funding, together with grants announced at the end of last year, fulfill the $30 million commitment the NFL made to the NIH in 2012. This fall, the NIH will convene public and private funders of concussion and TBI research, including NIH, the NFL, DoD, and NCAA, with the goal of supporting enhanced coordination among research efforts and better leveraging of public and private investments to accelerate research outcomes.”

    Google – President Applauds Commitments to Address Sports-Related Concussions
    To read the full White House press release.

  • Reply to

    White House Press Release on TBI

    by repo_man_one Jun 5, 2014 10:42 AM
    repo_man_one repo_man_one Jun 5, 2014 10:45 AM Flag

    Then this from RCPI 10Q:

    “On Sunday, November 10, Dr. Scott Ferguson of the Roskamp Institute presented data on anatabine as a potential treatment for traumatic brain injury (TBI). The study, which was funded by the Department of Defense and the Roskamp Foundation, used a published preclinical laboratory model of mild repetitive TBI, developed by the Roskamp team, which demonstrates cognitive impairment and neuropathological changes consistent with human TBI patients. Dr. Ferguson showed that chronic treatment with anatabine significantly improved cognitive performance in the TBI group, and significantly reduced TBI-induced inflammatory responses in the brain. The significance of repetitive mild brain injury, and its negative long term consequences on health, has become increasingly evident over the past few years both from military statistics on TBI in troops, and the data from athletes such as NFL players who have suffered multiple concussions. These data from the Roskamp Institute TBI program support investigation of anatabine as a potential treatment for TBI.”

    Hey Shorts, can you connect the dots?

  • repo_man_one repo_man_one Jun 5, 2014 11:55 AM Flag

    "Where are the test results"

    Have you read the 3Q 10Q?

    “On Sunday, November 10, Dr. Scott Ferguson of the Roskamp Institute presented data on anatabine as a potential treatment for traumatic brain injury (TBI). The study, which was funded by the Department of Defense and the Roskamp Foundation....."

  • Overview

    "We are looking to collaborate and/or partner with larger, more established, pharmaceutical companies who have interest in our potential target indications. Our preferred partner would have access to an experienced sales and marketing organization with an expertise in primary care markets on a national scale. We plan on developing compounds for FDA approval and commercialization, and would like to work with those who have the ability to market and distribute our products.

    We are also interested in working with the numerous non-profit associations, societies, and government organizations who are focused and advocates for inflammatory and CNS disorders. Such collaborations can often lead to funds, grants, and relationships which will help bring therapeutics within specific indications to market. "

    My guess is the TBI news falls into this category and I believe Dr Mullan can get that collaboration, despite all the rhetoric from the shorts.

  • repo_man_one repo_man_one Jun 6, 2014 11:56 AM Flag

    Can you read dummy?
    it's say "anatabine"
    Do you know what that is?

    When you clowns get forced to cover, lets see what the price is then

  • repo_man_one repo_man_one Jun 6, 2014 1:21 PM Flag

    Hope they picked an honest venue/judge who is willing to get to the truth.

  • repo_man_one repo_man_one Jun 6, 2014 1:23 PM Flag

    In other words, why file in Chicago, home of this countries biggest liar.

  • Reply to

    White House Press Release on TBI

    by repo_man_one Jun 5, 2014 10:42 AM
    repo_man_one repo_man_one Jun 8, 2014 9:44 PM Flag

    Looks like the shorts don't want to contest this one.

  • Did the FDA approve that because the old web site had that removed didn't it?

  • Reply to

    New Web Site has a PUBLICATIONS section

    by repo_man_one Jun 8, 2014 9:47 PM
    repo_man_one repo_man_one Jun 9, 2014 12:54 PM Flag

    Shorts have all the answers, but don't want to answer this question.
    Why?

  • repo_man_one by repo_man_one Jun 9, 2014 9:18 PM Flag

    Merck will buy Idenix Pharmaceuticals for $3.85 billion, bolstering its ability to compete in the growing market for hepatitis C drugs, the companies said Monday.......

    An estimated 3 million people in the USA are chronically infected with hepatitis C, the nation's leading cause of liver cancer and liver transplants. About half or more of those with hepatitis C don't know they have it.

    Idenix had a net loss of $122.3 million on revenue of $500,000 last year.

  • Reply to

    Holy Moley

    by repo_man_one Jun 9, 2014 9:18 PM
    repo_man_one repo_man_one Jun 9, 2014 10:27 PM Flag

    Only 3 million people with this and Merck paid what?
    How many people can be helped with Anatabloc?

  • on a Florida radio station.
    A dietary supplement for memory from jelly fish, or something like that.

  • Reply to

    Just Heard Dennis Miller hocking Pravagen

    by repo_man_one Jun 24, 2014 12:24 PM
    repo_man_one repo_man_one Jun 24, 2014 1:01 PM Flag

    Now this is interesting, according to a published article (Google - The FDA looks into Quincy Bioscience's claims for Prevagen), Quincy received an FDA warning letter back in 2012.

    "On Oct. 16, 2012, the FDA issued a warning letter, stating that Quincy was selling "unapproved new drugs" -- and not dietary supplements -- based on the unverified health claims on its website and Facebook page of "miraculous" cures of memory loss, including from Alzheimer's and dementia. The FDA further alleged that Quincy failed to report more than 1,000 "adverse events" among Prevagen users, including some that required hospitalization."

    "When asked about the FDA's assertion that Quincy "failed to report serious adverse events...like seizures, strokes and worsening symptoms of multiple sclerosis that had been reported to your firm as being associated with the use of Prevagen products," Underwood admits "we needed to sharpen our paperwork" on recording complaints. But he says serious problems only numbered about a dozen and argues they weren't evidence of a problem with Prevagen. "We sell a product to an elderly population, and they do have strokes. They do have issues," he says. "But we don't have evidence in any of those cases that our product is causative.""

    The article also goes on to say

    "Quincy Bioscience, the fast-growing Madison brain supplement maker, has all but settled its problems with the federal Food and Drug Administration, says Quincy president Mark Underwood. "To make a long story short, we're in a fine place with the FDA," says Underwood. "We've been able to satisfy all of their requests.""

    "Today, Prevagen is available at more than 20,000 retail locations, including Walgreen's and CVS drugstores, and it's sold online as well. Inc. magazine says Quincy's annual revenue has grown 234% from 2009 to 2012 -- from $5.3 million to $17.8 million."

    Well, well, isn't that interesting?

  • Reply to

    Just Heard Dennis Miller hocking Pravagen

    by repo_man_one Jun 24, 2014 12:24 PM
    repo_man_one repo_man_one Jun 24, 2014 1:09 PM Flag

    "based on a synthesized version of a jellyfish protein called apoaequorin."

  • repo_man_one repo_man_one Jun 24, 2014 2:13 PM Flag

    NO response, I expected that

SNE
19.11+0.21(+1.11%)Aug 29 4:05 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.